Peter Kolchinsky
Director at Artiva Biotherapeutics, Inc. (ARTV); Director at Climb Bio, Inc. (CLYM); 10% Owner at Hemab Therapeutics Holdings, Inc. (COAG); 10% Owner at Werewolf Therapeutics, Inc. (HOWL); Director at Sionna Therapeutics, Inc. (SION); Director at Vor Biopharma Inc. (VOR)
Purchase track record
Strong record. Based on 3 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 23SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 120,58217,098,479 held (+1%) | $9.55 | $1.2M | -27.3% |
| Jul 23SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 84,12417,182,603 held (+0%) | $9.93 | $835K | -30.1% |
| Jul 23SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 59,88017,242,483 held (+0%) | $9.96 | $596K | -30.3% |
| Jun 16SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 391,01916,622,736 held (+2%) | $8.57 | $3.4M | -19.0% |
| Jun 16SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 15,41416,638,150 held (+0%) | $8.99 | $139K | -22.8% |
| Jun 16SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 124,89316,763,043 held (+1%) | $8.89 | $1.1M | -21.9% |
| Jun 11SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 345,2355,364,623 held (−6%) | $0.37 | $128K | +164.9% |
| Jun 11SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 24,565381,717 held (−6%) | $0.37 | $9K | +164.9% |
| Jun 11SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 42,8725,321,751 held (−1%) | $0.37 | $16K | +164.9% |
| Jun 11SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 3,051378,666 held (−1%) | $0.37 | $1K | +164.9% |
| Jun 11SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 245,0665,076,685 held (−5%) | $0.38 | $93K | +157.9% |
| Jun 11SEC | HOWLWerewolf Therapeutics, Inc. | Sell | 17,437361,229 held (−5%) | $0.38 | $7K | +157.9% |
| May 14SEC | COAGHemab Therapeutics Holdings, Inc. | Buy | 6,3876,372,170 held (+0%) | $24.90 | $159K | +27.0% |
| Apr 6SEC | VORVor Biopharma Inc. | Sell | 258,4755,146,523 held (−5%) | $18.23 | $4.7M | +9.2% |
| Apr 6SEC | VORVor Biopharma Inc. | Sell | 1,5255,144,998 held (−0%) | $19.06 | $29K | +4.4% |
| Apr 6SEC | VORVor Biopharma Inc. | Sell | 537,7544,607,244 held (−10%) | $16.51 | $8.9M | +20.5% |
| Apr 6SEC | VORVor Biopharma Inc. | Sell | 44,7284,562,516 held (−1%) | $17.31 | $774K | +15.0% |
| Apr 6SEC | VORVor Biopharma Inc. | Sell | 6,7754,555,741 held (−0%) | $18.50 | $125K | +7.6% |
| Dec 15SEC | CLYMClimb Bio, Inc. | Buy | 213,0993,294,856 held (+7%) | $2.18 | $465K | +404.6% |
| Dec 15SEC | CLYMClimb Bio, Inc. | Buy | 101,4623,396,318 held (+3%) | $2.86 | $290K | +284.6% |
| Nov 24SEC | SIONSionna Therapeutics, Inc. | Sell | 1506,898,929 held (−0%) | $39.89 | $6K | -87.7% |
| Nov 24SEC | SIONSionna Therapeutics, Inc. | Sell | 1,235661,019 held (−0%) | $39.89 | $49K | -87.7% |
| Nov 24SEC | SIONSionna Therapeutics, Inc. | Sell | 8012,205,034 held (−0%) | $39.89 | $32K | -87.7% |
| Nov 24SEC | SIONSionna Therapeutics, Inc. | Sell | 947167,246 held (−1%) | $39.89 | $38K | -87.7% |
| Nov 24SEC | SIONSionna Therapeutics, Inc. | Sell | 966,898,833 held (−0%) | $40.50 | $4K | -87.9% |
| Nov 24SEC | SIONSionna Therapeutics, Inc. | Sell | 788660,231 held (−0%) | $40.50 | $32K | -87.9% |
| Nov 24SEC | SIONSionna Therapeutics, Inc. | Sell | 5122,204,522 held (−0%) | $40.50 | $21K | -87.9% |
| Nov 24SEC | SIONSionna Therapeutics, Inc. | Sell | 604166,642 held (−0%) | $40.50 | $24K | -87.9% |
| Nov 24SEC | SIONSionna Therapeutics, Inc. | Sell | 1,2106,897,623 held (−0%) | $39.50 | $48K | -87.6% |
| Nov 24SEC | SIONSionna Therapeutics, Inc. | Sell | 9,924650,307 held (−2%) | $39.50 | $392K | -87.6% |
| Nov 24SEC | SIONSionna Therapeutics, Inc. | Sell | 6,4402,198,082 held (−0%) | $39.50 | $254K | -87.6% |
| Nov 24SEC | SIONSionna Therapeutics, Inc. | Sell | 7,609159,033 held (−5%) | $39.50 | $301K | -87.6% |
| Oct 30SEC | VORVor Biopharma Inc. | Sell | 87,8281,092,232 held (−7%) | $27.10 | $2.4M | -26.6% |
| Oct 30SEC | VORVor Biopharma Inc. | Sell | 36,4831,055,749 held (−3%) | $28.18 | $1.0M | -29.4% |
| Oct 30SEC | VORVor Biopharma Inc. | Sell | 251,518804,231 held (−24%) | $25.22 | $6.3M | -21.1% |
| Oct 30SEC | VORVor Biopharma Inc. | Sell | 24,579779,652 held (−3%) | $25.12 | $617K | -20.8% |
- Buy
Director Peter Kolchinsky bought $3.4M of ARTV at $8.57 — first open-market purchase in our records.
- Buy
10% Owner Peter Kolchinsky bought $159K of COAG at $24.90 — first open-market purchase in our records.
- Buy
Director Peter Kolchinsky bought $465K of CLYM at $2.18 — first open-market purchase in our records.